Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Research Area
  • Alzheimer´s Disease
  • Bone Metabolism
  • Cardiovascular
  • Cell Proliferation
  • Covid-19 Pneumonia
  • Cytokines
  • Heart Disease
  • Immunology
  • Infectious Disease
  • Inflammation
  • Metabolic Disease
  • Nephrology & Transplant
  • Neurology
  • Oncology
  • Oxidative Stress
  • Toxicity

Featured Products & Promotions

Latest News
  • Classification of Vitamin D status based its metabolism
    Classification of Vitamin D status based on its metabolism
    10 March, 2025
    Our Fibroblast Growth Factor-23 (FGF-23) C-terminal ELISA assay was highlighted in a recent clinical study in hypertensive patients. The researchers evaluated whether individuals with “functional vitamin D deficiency” significantly benefit from vitamin D supplementation. As of now, there is no widely accepted definition of functional vitamin D deficiency. Thus, the authors explored the hypothesis that [...]
  • Cardiac Safety Biomarkers for Toxicity Testing
    Cardiac Safety Biomarkers for Toxicity Testing
    3 March, 2025
    Biomarkers have long been used as indicators of biological changes. In the context of drug development, they serve two key functions: predicting drug efficacy and detecting potential toxicity. Cardiotoxicity is a significant reason for the failure of preclinical safety tests during the drug development process. Consequently, monitoring cardiac toxicity through biomarkers is a crucial component [...]
  • NT-proANP - a Biomarker for Cardiac Risk
    NT-proANP - a Biomarker for Cardiac Risk
    24 February, 2025
    The BIOMEDICA cardiac biomarker kits NT-proBNP and NT-proANP were used in a recent study exploring the potential for increased cardiovascular complications due to radioactive iodine treatment (RAI) effects in patients with differentiated thyroid cancer (DTC) with or without type 2 diabetes. The Interplay Between High Cumulative Doses of Radioactive Iodine and Type 2 Diabetes Mellitus: [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events